BioCentury | Oct 22, 2007
Company News

NiKem, Servier deal

...that inhibit undisclosed kinases for Servier. Financial terms of the one-year deal were not disclosed. NiKem Research s.r.l....
BioCentury | Jul 2, 2007
Company News

InterMune, NiKem deal

...InterMune. Financial terms of the one-year deal were not disclosed. InterMune Inc. (ITMN), Brisbane, Calif. NiKem Research s.r.l....
BioCentury | Apr 30, 2007
Company News

NiKem neurology news

...BND-001 by mid-2008. The newco will seek to raise a series A round by mid-2007. NiKem...
...hired as Brane's CSO and CMO. Giuseppe Giardina was promoted from COO to CEO of NiKem...
..."were formerly perceived as a potential 'conflict of interest' issue by some of NiKem's clients." NiKem Research s.r.l....
BioCentury | Apr 16, 2007
Emerging Company Profile

Corporate Profile

...University of Zurich Corporate partners: Chembiotek Research International Pvt. Ltd., Syngene International Pvt. Ltd., and NiKem...
BioCentury | Apr 9, 2007
Company News

Neurotune, NiKem deal

...The companies will use NiKem's chemistry and preclinical technologies to design, synthesize and optimize compounds against...
...IP. Financial terms of the one-year deal were not disclosed. Neurotune AG , Zurich, Switzerland NiKem Research s.r.l....
BioCentury | May 16, 2005
Company News

Hybrigenics SA, NiKem Research Srl deal

...The companies extended their cancer research deal under which NiKem is using its medicinal chemistry technology...
...medicinal chemistry technology to optimize Hybrigenics' inhibitors of ubiquitin-specific proteases. Hybrigenics SA , Paris, France NiKem...
BioCentury | Aug 11, 2003
Strategy

GSK's trading post

...peptide Preclin 500,000 shares plus 1.9M shares in milestones MerLion Natural product libraries NA Undisclosed NiKem...
BioCentury | Jun 23, 2003
Emerging Company Profile

Newron: Better channel management

...screening and medicinal chemistry work is done via fee-for-service partners Axxam srl (Milan, Italy) and NiKem Research s.r.l....
BioCentury | Jun 23, 2003
Emerging Company Profile

Corporate Profile

...Founded: 1999 by Luca Benatti, Ruggero Fariello, Patricia Salvati Corporate partners: Vicuron Pharma; Axxam srl; NiKem Research s.r.l....
Items per page:
1 - 9 of 9
BioCentury | Oct 22, 2007
Company News

NiKem, Servier deal

...that inhibit undisclosed kinases for Servier. Financial terms of the one-year deal were not disclosed. NiKem Research s.r.l....
BioCentury | Jul 2, 2007
Company News

InterMune, NiKem deal

...InterMune. Financial terms of the one-year deal were not disclosed. InterMune Inc. (ITMN), Brisbane, Calif. NiKem Research s.r.l....
BioCentury | Apr 30, 2007
Company News

NiKem neurology news

...BND-001 by mid-2008. The newco will seek to raise a series A round by mid-2007. NiKem...
...hired as Brane's CSO and CMO. Giuseppe Giardina was promoted from COO to CEO of NiKem...
..."were formerly perceived as a potential 'conflict of interest' issue by some of NiKem's clients." NiKem Research s.r.l....
BioCentury | Apr 16, 2007
Emerging Company Profile

Corporate Profile

...University of Zurich Corporate partners: Chembiotek Research International Pvt. Ltd., Syngene International Pvt. Ltd., and NiKem...
BioCentury | Apr 9, 2007
Company News

Neurotune, NiKem deal

...The companies will use NiKem's chemistry and preclinical technologies to design, synthesize and optimize compounds against...
...IP. Financial terms of the one-year deal were not disclosed. Neurotune AG , Zurich, Switzerland NiKem Research s.r.l....
BioCentury | May 16, 2005
Company News

Hybrigenics SA, NiKem Research Srl deal

...The companies extended their cancer research deal under which NiKem is using its medicinal chemistry technology...
...medicinal chemistry technology to optimize Hybrigenics' inhibitors of ubiquitin-specific proteases. Hybrigenics SA , Paris, France NiKem...
BioCentury | Aug 11, 2003
Strategy

GSK's trading post

...peptide Preclin 500,000 shares plus 1.9M shares in milestones MerLion Natural product libraries NA Undisclosed NiKem...
BioCentury | Jun 23, 2003
Emerging Company Profile

Newron: Better channel management

...screening and medicinal chemistry work is done via fee-for-service partners Axxam srl (Milan, Italy) and NiKem Research s.r.l....
BioCentury | Jun 23, 2003
Emerging Company Profile

Corporate Profile

...Founded: 1999 by Luca Benatti, Ruggero Fariello, Patricia Salvati Corporate partners: Vicuron Pharma; Axxam srl; NiKem Research s.r.l....
Items per page:
1 - 9 of 9